A detailed history of M3 Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, M3 Advisory Group, LLC holds 1,128 shares of AMGN stock, worth $356,448. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,128
Previous 1,144 1.4%
Holding current value
$356,448
Previous $357 Million 1.73%
% of portfolio
0.27%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$309.38 - $337.38 $4,950 - $5,398
-16 Reduced 1.4%
1,128 $364 Million
Q2 2024

Jul 19, 2024

BUY
$262.75 - $319.31 $17,078 - $20,755
65 Added 6.02%
1,144 $357 Million
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $29,844 - $36,026
-111 Reduced 9.33%
1,079 $307 Million
Q4 2023

Mar 19, 2024

BUY
$255.7 - $288.46 $304,283 - $343,267
1,190 New
1,190 $343 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track M3 Advisory Group, LLC Portfolio

Follow M3 Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M3 Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M3 Advisory Group, LLC with notifications on news.